Tumor treatment process and composition
US4895874A · kind A · utility
3Cited by
0References
19Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 1, 1984 |
| Grant date | Jan 23, 1990 |
| Priority date | — |
| Expiry date | Mar 1, 2004 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/20
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Saturated aliphatic straight chain dicarboxylic acids having a total number of carbon atoms which are divisible by four, are selectively toxic to certain tumor cells while non-toxic to normal cells of the same origin. Octacosanedioic acid is particularly preferred as it is a component of normal blood serum. Compositions containing these compounds may be used in the treatment of certain malignancies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.